HOOK (OTC)
HOOKIPA PHARMA INC
$1.040000
+0.040000 (+4.00%)
Prev close: $1.000000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jörn Aldag
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $103.37M
- Employees
- 151
- P/E (TTM)
- -9.66
- P/B (TTM)
- 0.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $178.70M |
| Benefits Costs and Expenses | $190.89M |
| Cost Of Revenue | $126.39M |
| Costs And Expenses | $190.89M |
| Gross Profit | $52.31M |
| Operating Expenses | $63.39M |
| Selling, General, and Administrative Expenses | $63.39M |
| Operating Income/Loss | -$11.08M |
| Income/Loss From Continuing Operations After Tax | -$7.14M |
| Income/Loss From Continuing Operations Before Tax | -$12.19M |
| Income Tax Expense/Benefit | -$5.05M |
| Income Tax Expense/Benefit, Deferred | -$2.74M |
| Interest Expense, Operating | $1.61M |
| Net Income/Loss | -$7.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 58,525,000 |
| Diluted Average Shares | 58,855,000 |
| Assets | $269.62M |
| Current Assets | $56.64M |
| Inventory | $21.86M |
| Other Current Assets | $34.78M |
| Noncurrent Assets | $212.98M |
| Fixed Assets | $118.84M |
| Other Non-current Assets | $94.15M |
| Liabilities | $142.92M |
| Current Liabilities | $38.81M |
| Accounts Payable | $20.30M |
| Wages | $4.84M |
| Other Current Liabilities | $13.68M |
| Noncurrent Liabilities | $104.11M |
| Equity | $126.70M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $126.70M |
| Liabilities And Equity | $269.62M |
| Net Cash Flow From Operating Activities | $14.93M |
| Net Cash Flow From Operating Activities, Continuing | $14.93M |
| Net Cash Flow From Investing Activities | -$17.45M |
| Net Cash Flow From Investing Activities, Continuing | -$17.45M |
| Net Cash Flow From Financing Activities | $1.69M |
| Net Cash Flow From Financing Activities, Continuing | $1.69M |
| Net Cash Flow | -$832.00K |
| Net Cash Flow, Continuing | -$832.00K |
| Comprehensive Income/Loss | -$7.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.30M |
| Other Comprehensive Income/Loss | -$7.30M |